Binary Subclassification Scheme (AUS-Nuclear versus AUS-Other) Adequately Risk-Stratifies Thyroid Fine Needle Aspiration Spec
Tracking # 20-1281240
$99999.00
There are no ratings for this course
Learn moreCourse overview
The eJournal is an online pathology journal club that reviews current articles from a peer-reviewed cytopathology Journal. Participants will be able to review the journal article, commentary and webinar from the contributing author. This is a great self-assessment, teaching and continuing education tool. Target Audience This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community. Learning Objectives To understand the role of nuclear atypia in determining the risk of malignancy in AUS thyroid nodules To assess the clinical impact of molecular testing in managing AUS thyroid nodules To discuss the potential benefits of adopting a binary subclassification scheme for AUS thyroid nodules in clinical practice Presenter(s): Seyedreza Mousavi MD, MS, CT(ASCP), MB, CT(IAC) Michiya Nishino, MD, PhD
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
The presenters have no conflicts of interest or financial relationships to disclose.